Overview

Olanzapine in Patients With Borderline Personality Disorder

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The goals of this study are to determine: the safety of olanzapine and any side effects that might be associated with it, how olanzapine compares to placebo, whether olanzapine can help patients with symptoms of Borderline Personality Disorder (BPD), and how much olanzapine should be given to patients.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Olanzapine